Cases
Cases 1 - 10 of 384
Sandoz Inc. v. Boehringer Ingelheim Pharmaceuticals Inc. et al
as 1:2024cv01192
Defendant: Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals Inc.
Plaintiff: Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2024cv00082
Defendant: Mylan Pharmaceuticals Inc., Mylan Laboratories Limited and Mylan Inc.
Plaintiff: Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Counter-Claimant: Mylan Pharmaceuticals Inc., Mylan Laboratories Limited and Mylan Inc.
Counter-Defendant: Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Granules India Limited
as 1:2024cv00753
Plaintiff: Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH and others
Defendant: Granules India Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Apotex Inc. v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
as 1:2024cv00577
Plaintiff: Apotex Inc.
Defendant: Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. ALVOGEN, INC.
as 2:2023cv03911
Plaintiff: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM INTERNATIONAL GMBH and BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Defendant: ALVOGEN, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. ALVOGEN, INC.
as 3:2023cv03911
Plaintiff: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM INTERNATIONAL GMBH and BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Defendant: ALVOGEN, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Apotex Inc. et al We have downloadable decisions or orders for this case
as 1:2023cv00685
Plaintiff: Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and others
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Hetero USA Inc. et al
as 1:2023cv00048
Plaintiff: Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and others
Defendant: Hetero USA Inc., Hetero Labs Limited Unit-V and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Cipla Ltd. v. Boehringer Ingelheim Pharmaceuticals Inc. et al
as 1:2022cv00300
Plaintiff: Cipla Ltd.
Defendant: Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. QILU PHARMA INC.
as 2:2021cv00564
Plaintiff: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant: Qila Pharma Inc. and QILU PHARMA INC.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?